Category Archives: Social Media

Collection of FDA and Social Media Resources

Many years have passed since FDA began attempting to enunciate a regulatory approach to digital and social media – beginning in 2009 and still presumably on-going.  In June the most substantive guidance yet was released by the agency addressing two … Continue reading

Posted in FDA Policy, Social Media | Leave a comment

Guidance on Two Social Media Fronts from FDA’s OPDP

For four and half years now FDA’s OPDP has endeavored to devise answers to 5 questions raised during a public hearing on the Internet, Social Media and Pharma and Device Manufacturers held in April 2009.  Finally, on a day when … Continue reading

Posted in Social Media | Comments Off

Looking Beyond Patient Engagement for Pharma and Social Media

As we wait for the anticipated guidance from FDA regarding the use of social media by the pharmaceutical industry, one of the many aspects discussed as been that of patient engagement with the industry.  The Internet is highly utilized for … Continue reading

Posted in Social Media | 3 Comments

Sunset on the ROI of Social Media and Pharma Discussion

While many pharma companies have developed a wide and deep footprint in social media, many others have not.  When exploring the issue of whether or not to involve a brand, there are several questions to consider.  Some are very important … Continue reading

Posted in Social Media | 4 Comments

OPDP Issues Untitled Letter Involving Social Media

Sort of. There is, of course, a difference between a regulatory action letter that is issued because of a social media use and a regulatory action letter that is issued the communication happens to involve a social media platform.  In … Continue reading

Posted in Social Media, Warning Letters | 1 Comment